KBC Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

KBC Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-23,107	Closed	-$953K	–	1421
2015 Q2	$953K	Sell	23,107 -6,571	-22%	-$236K	0.01%	736
2015 Q1	$1.05M	Buy	29,678 +22,822	+333%	+$772K	0.01%	720
2014 Q4	$220K	Buy	+6,856	New	+$198K	﹤0.01%	1175

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

KBC Group's BRLI Position: Q3 2015 in Review

KBC Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 23,107 shares — an estimated $953K sold.

KBC Group first reported a position in BRLI in Q4 2014 and held it in 3 quarters. The position peaked at $1.05M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

KBC Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
KBC Group sold 23,107 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $953K.
KBC Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2014 and held it in 3 quarters.
KBC Group's BIO-REFERENCE LABS INC-NEW- position peaked at $1.05M in Q1 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on KBC Group's 13F filing for Q3 2015, filed 12 Nov 2015.